As of April 16, 2025, Immunovant (IMVT) has a market cap of $2.63 billion USD. According to our data, Immunovant is ranked No.3548 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $2.63 B |
-37.57%
|
Dec 31, 2024 | $4.21 B |
-41.21%
|
Dec 29, 2023 | $7.16 B |
137.35%
|
Dec 30, 2022 | $3.02 B |
108.33%
|
Dec 31, 2021 | $1.45 B |
-81.55%
|
Dec 31, 2020 | $7.85 B |
191.05%
|
Dec 31, 2019 | $2.70 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Argenx
ARGX
|
$36.92 B |
0.002 M
|
![]() Netherlands
|
![]() BioCryst Pharmaceuticals
BCRX
|
$1.55 B |
-0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
Market Cap | = | IMVT Stock Price | * | IMVT Shares Outstanding |
= | $15.47 | * | 0.17 B | |
= | $2.63 B |